hierarchical linear regression model Search Results


linear regression model  (RStudio)
90
RStudio linear regression model
Linear Regression Model, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/linear+regression+model/10__3390_slash_f13020151-101-2-12
Average 90 stars, based on 1 article reviews
linear regression model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear model  (Schmid GmbH)
90
Schmid GmbH linear model
Linear Model, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/linear+regression+model/10__1016_slash_j__gecco__2025__e03609-146-6-14
Average 90 stars, based on 1 article reviews
linear model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear model  (OriginLab corp)
90
OriginLab corp linear model
Linear Model, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/linear+regression+model/bio_rxiv__2025__07__16__665088-177-2-28
Average 90 stars, based on 1 article reviews
linear model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hierarchical generalized linear models (hglm) package  (vsn international)
90
vsn international hierarchical generalized linear models (hglm) package
Hierarchical Generalized Linear Models (Hglm) Package, supplied by vsn international, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/hierarchical+generalized+linear+models++hglm++package/pm20002231-96-11-21
Average 90 stars, based on 1 article reviews
hierarchical generalized linear models (hglm) package - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
multilevel modeling in hlm  (SSI Inc)
90
SSI Inc multilevel modeling in hlm
Multilevel Modeling In Hlm, supplied by SSI Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/hierarchical+linear+modeling++hlm++software+version+7+01/pmc07524495-156-7-12
Average 90 stars, based on 1 article reviews
multilevel modeling in hlm - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear regression model r version 6.3.1  (RStudio)
90
RStudio linear regression model r version 6.3.1
Linear Regression Model R Version 6.3.1, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/linear+regression+model+r+version+6+3+1/pm32235877-264-5-8
Average 90 stars, based on 1 article reviews
linear regression model r version 6.3.1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
pain interference hierarchical linear model  (ProMIS Neurosciences)
90
ProMIS Neurosciences pain interference hierarchical linear model
Likert <t>Pain</t> Scale <t>Hierarchical</t> <t>Linear</t> <t>Model</t> and PROMIS Pain <t>Interference</t> Hierarchical Linear Model
Pain Interference Hierarchical Linear Model, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/pain+interference+hierarchical+linear+model/pmc10629716-183-15-14
Average 90 stars, based on 1 article reviews
pain interference hierarchical linear model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear regression model  (Meditron GmbH)
90
Meditron GmbH linear regression model
Likert <t>Pain</t> Scale <t>Hierarchical</t> <t>Linear</t> <t>Model</t> and PROMIS Pain <t>Interference</t> Hierarchical Linear Model
Linear Regression Model, supplied by Meditron GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/linear+regression+model/med_rxiv__2024__10__14__24315448-81-5-0
Average 90 stars, based on 1 article reviews
linear regression model - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
log–log transformed linear model (regression analysis in rstudio 1.0.136)  (RStudio)
90
RStudio log–log transformed linear model (regression analysis in rstudio 1.0.136)
Likert <t>Pain</t> Scale <t>Hierarchical</t> <t>Linear</t> <t>Model</t> and PROMIS Pain <t>Interference</t> Hierarchical Linear Model
Log–Log Transformed Linear Model (Regression Analysis In Rstudio 1.0.136), supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/log+log+transformed+linear+model++regression+analysis+in+rstudio+1+0+136+/pmc06360077-106-20-27
Average 90 stars, based on 1 article reviews
log–log transformed linear model (regression analysis in rstudio 1.0.136) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
linear regression analysis xlstat  (Addinsoft inc)
90
Addinsoft inc linear regression analysis xlstat
Likert <t>Pain</t> Scale <t>Hierarchical</t> <t>Linear</t> <t>Model</t> and PROMIS Pain <t>Interference</t> Hierarchical Linear Model
Linear Regression Analysis Xlstat, supplied by Addinsoft inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/multiple+linear+regression+model/pm34663792-376-1-5
Average 90 stars, based on 1 article reviews
linear regression analysis xlstat - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
gp2 igg  (CH Instruments)
90
CH Instruments gp2 igg
Rate of <t> anti-GP2 </t> antibody positivity in the UC, CD, and control groups
Gp2 Igg, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/linear+regression+model/pmc06389294-144-37-92
Average 90 stars, based on 1 article reviews
gp2 igg - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
hierarchical bayesian multinomial logistic regression model pyr0  (Broad Institute Inc)
90
Broad Institute Inc hierarchical bayesian multinomial logistic regression model pyr0
Rate of <t> anti-GP2 </t> antibody positivity in the UC, CD, and control groups
Hierarchical Bayesian Multinomial Logistic Regression Model Pyr0, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hierarchical+linear+regression+model/hierarchical+bayesian+multinomial+logistic+regression+model+pyr0/pm37759666-334-17-7
Average 90 stars, based on 1 article reviews
hierarchical bayesian multinomial logistic regression model pyr0 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Likert Pain Scale Hierarchical Linear Model and PROMIS Pain Interference Hierarchical Linear Model

Journal: Muscle & nerve

Article Title: A Secondary Analysis of Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Pain’s Impact on Sleep, Fatigue, and Activities of Daily Living

doi: 10.1002/mus.27637

Figure Lengend Snippet: Likert Pain Scale Hierarchical Linear Model and PROMIS Pain Interference Hierarchical Linear Model

Article Snippet: Open in a separate window Figure 2: Likert Pain Scale Hierarchical Linear Model and PROMIS Pain Interference Hierarchical Linear Model. Open in a separate window Figure 4: SF-12 Physical Component Scale (PCS) Hierarchical Linear Model and SF-12 Mental Component Scale (MCS) Hierarchical Linear Model.

Techniques:

SF-12 Physical Component Scale (PCS) Hierarchical Linear Model and SF-12 Mental Component Scale (MCS) Hierarchical Linear Model

Journal: Muscle & nerve

Article Title: A Secondary Analysis of Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Pain’s Impact on Sleep, Fatigue, and Activities of Daily Living

doi: 10.1002/mus.27637

Figure Lengend Snippet: SF-12 Physical Component Scale (PCS) Hierarchical Linear Model and SF-12 Mental Component Scale (MCS) Hierarchical Linear Model

Article Snippet: Open in a separate window Figure 2: Likert Pain Scale Hierarchical Linear Model and PROMIS Pain Interference Hierarchical Linear Model. Open in a separate window Figure 4: SF-12 Physical Component Scale (PCS) Hierarchical Linear Model and SF-12 Mental Component Scale (MCS) Hierarchical Linear Model.

Techniques:

Rate of anti-GP2 antibody positivity in the UC, CD, and control groups

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Rate of anti-GP2 antibody positivity in the UC, CD, and control groups

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: Control

ROC analysis for GP2 and ASCA antibodies between the patients with Crohn’s disease and the control group.

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: ROC analysis for GP2 and ASCA antibodies between the patients with Crohn’s disease and the control group.

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: Control

ROC analysis for GP2 and ASCA antibodies between the patients with Crohn’s disease and UC

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: ROC analysis for GP2 and ASCA antibodies between the patients with Crohn’s disease and UC

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

ROC curve for GP2 and ASCA antibodies in Crohn’s disease and the control

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: ROC curve for GP2 and ASCA antibodies in Crohn’s disease and the control

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: Control

ROC curve for GP2 and ASCA antibodies in Crohn’s disease and ulcerative colitis patients

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: ROC curve for GP2 and ASCA antibodies in Crohn’s disease and ulcerative colitis patients

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Combination of ASCA and anti-GP2 antibodies

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Combination of ASCA and anti-GP2 antibodies

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Rates of positivity for ASCA and anti-GP2 antibodies

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Rates of positivity for ASCA and anti-GP2 antibodies

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: Control

Sensitivity, specificity, PPV, and NPV for anti-GP2 and ASCA in patients with CD

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Sensitivity, specificity, PPV, and NPV for anti-GP2 and ASCA in patients with CD

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Correlations between antibody positivity and disease behavior and area of involvement in patients with CD

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Correlations between antibody positivity and disease behavior and area of involvement in patients with CD

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Correlations between perianal involvement and antibody positivity in patients with CD

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Correlations between perianal involvement and antibody positivity in patients with CD

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques:

Correlations between antibody positivity and surgical history in patients with CD

Journal: The Turkish Journal of Gastroenterology

Article Title: Differential diagnosis of Crohn’s disease using antibodies to glycoprotein 2 and Saccharomyces cerevisiae

doi: 10.5152/tjg.2018.18135

Figure Lengend Snippet: Correlations between antibody positivity and surgical history in patients with CD

Article Snippet: The GP2 IgG levels were similar in the three groups (Kruskal-Wallis test, p=0.323). table ft1 table-wrap mode="anchored" t5 caption a7 UC (n=62) CD (n=60) Control (n=46) p GP2 IgA (+) 2 (3%) 15 (25%) 1 (2%) <0.001 GP2 IgG (+) 3 (5%) 3 (5%) 0 / 46 0.309 GP2 total (+) 3 (5%) 15 (25%) 1 (2%) <0.001 ASCA IgA (+) 7 (11%) 25 (42%) 1 (2%) <0.001 ASCA IgG (+) 9 (15%) 19 (32%) 0/46 <0.001 ASCA total (+) 14 (23%) 31 (52%) 1 (2%) <0.001 Open in a separate window Chi-square test.

Techniques: